Both are made by Eli Lilly, but tirzepatide is a dual-agonist (GLP-1 + GIP) while retatrutide is a triple-agonist (GLP-1 + GIP + glucagon)
Xin, Y., Jiang, X., Wang, Y., Su, X., Sun, M., Zhang, L., et al
For individuals prescribed semaglutide for type 2 diabetes management, many insurance plans, including Medicare and Medicaid, tend to provide some level of coverage
Coupled with high temperatures and humidity, this may push you into dehydration faster, even on a seemingly normal day
With clinical studies already showing remarkable outcomes, retatrutide may soon redefine the future of obesity and diabetes care
The drug works by mimicking the effects of GLP-1 and hitting receptors for another hormone, GIP, which leads to even more weight loss